NCCRT Learning Center

The NCCRT Learning Center is a digital learning platform which features courses, tools, and other resources on colorectal cancer screening delivery and research. Current educational offerings include:

  • The Colonoscopy Needs Calculator—This tool estimates the number of colonoscopies your practice can realistically anticipate with a high-quality stool-based colorectal cancer screening program based on various screening rate goals and other data inputs. It also provides an estimation of what the total colonoscopy need would cost a system as well as a comparison between the costs of treating cancer and costs of providing colonoscopies.
  • The Communications Education Portal—This course houses our suite of market research findings on the unscreened for colorectal cancer and messaging recommendations to more effectively develop communication campaigns and resources for unscreened populations. Learners can peruse the market research findings from start to finish or jump in to find just what you need to educate, empower, and mobilize those who are not getting screened for colorectal cancer.

We plan to populate the NCCRT Learning Center with additional tools and learning modules over time. Users can create an account to track your progress, learn when new content is released, and access more courses as they become available.

 

2021 USPSTF Colorectal Cancer Screening Recommendation Lowers Screening Age from 50 to 45: Implications for NCCRT Partners – June 7, 2021

On May 18, 2021, the United States Preventive Services Task Force (USPSTF) released a final Recommendation, Evidence Summary, and Modeling Study on screening for colorectal cancer. The primary difference from the previous 2016 recommendation is that average risk adults are now recommended to start screening at age 45, in alignment with the American Cancer Society’s 2018 recommendation.

During this NCCRT webinar, a panel of expert speakers discussed:

  • What changed in the new recommendation? And what data informed the decision to lower the screening age to 45?
  • How does the new recommendation impact insurance coverage and what is the timeline?
  • When will the new guideline be reflected in colorectal cancer screening quality measures and national screening rate indicators?
  • What data do we have on screening in 45-49 year olds and what do we know about them?
  • The experiences of one state (Indiana) that began implementing screening at age 45 statewide following legislation to lower the screening age in 2019.

Speakers:

  • Heather Dacus, DO, MPH; Director, Bureau of Cancer Prevention and Control, NYS Department of Health; NCCRT Policy Action Strategic Priority Team Co-chair (Moderator)
  • Robert Smith, PHD; Senior Vice President, Cancer Screening; American Cancer Society; NCCRT Co-chair
  • Anna Schwamlein Howard; Principal, Policy Development, Access to and Quality of Care; American Cancer Society Cancer Action Network
  • Sepheen Byron; Assistant Vice President of Performance Measurement, the National Committee for Quality Assurance 
  • Stacey Fedewa, PhD; Scientific Director, Screening and Risk Factors Surveillance; American Cancer Society
  • Bryan Hannon; Regional Government Relations Director; American Cancer Society Cancer Action Network

Continuing Education Courses for Healthcare Providers on Colorectal Cancer Screening

To provide up-to-date information on recommended best practices for colorectal cancer screening, the Centers for Disease Control and Prevention (CDC) partnered with Medscape Education to create two continuing education courses for healthcare providers.

In one of these courses, Screening for Colorectal Cancer: Recommended Best Practices (0.5 CME/CNE credits), David Lieberman, MD, of Oregon Health and Science University, leads a video lecture that explains why colorectal cancer screening is important, how to determine the timing and frequency of colorectal cancer screening, recommended stool-based and direct visualization screening strategies, and how to improve screening quality with a programmatic approach and quality metrics.

The second course, CRC Screening and Surveillance: Optimizing Quality (1.0 CME/CNE credits), is a three-part clinical anthology that includes more detail on these topics and explains the role of primary care providers in stool testing and colonoscopy programs.

These free courses are available for continuing education credit. You can create a free Medscape account and view the courses at: https://www.medscape.org/viewarticle/946291  and https://www.medscape.org/viewarticle/945988.

Evaluation: The courses were developed by nationally recognized experts in colorectal cancer screening, including primary care clinicians, gastroenterologists, and epidemiologists.

Permissions: Made publicly available online through Medscape Education.

Publication date: March 15 and 24, 2021.

Post date: March 31, 2021.

Contact: Submit comments, questions, and suggestions via the links on the Medscape Education website. 

Advanced Colorectal Polyp Brief

The National Colorectal Cancer Roundtable created the Advanced Colorectal Polyp GI Brief to help endoscopists and primary care clinicians identify patients with advanced colorectal polyps, understand the epidemiology and associated risk factors, and most importantly know the risks of colorectal neoplasia for patients with advanced colorectal polyps and their first-degree relatives (parents, siblings, children).

This brief aims to:

  1. Remind endoscopists that patients with an advanced colorectal polyp and their close relatives are at increased risk for advanced colorectal polyps and colorectal cancer;
  2. Keep endoscopists up to date with current guidelines; and,
  3. Provide template letters to communicate colonoscopy and pathology results, risk status, and follow-up recommendations for patients and close relatives.

Supplemental template letters: 

Learn more on how gastroenterologists and endoscopists can play a role in the national efforts to improve colorectal cancer screening rates:

Clinician’s Reference: Stool-Based Tests for Colorectal Cancer Screening

This newly revised resource is designed to introduce (or reintroduce) clinicians to the value of stool-based testing for colorectal cancer. It explains the different types of stool-based tests available—Fecal Immunochemical Tests (FIT), High-Sensitivity Fecal Occult Blood Tests (HS-gFOBT) and FIT-DNA testing—and provides guidance on implementing high quality stool-based screening programs. The resource now includes information on sensitivity and specificity for many of the most commonly used tests.

We would like to thank the following individuals, many from the NCCRT Professional Education and Practice Implementation Task Group, for reviewing past and current versions of this resource and contributing to this work: James Allison, Kim Andrews, Barry Berger, Durado Brooks, Gloria Coronado, Debbie Kirkland, Theodore Levin, Dorothy Lane, Laura Makaroff, Marion Nadel, Kerstin Ohlander, Mike Potter, Robert Smith, and Richard Wender. We’d also like to thank the Comprehensive Cancer Control Program National Partners for providing funding support.

The Dos and Don’ts of Colorectal Cancer Screening

This one-page flyer may be used to remind clinicians about some of the dos and don’ts when it comes to colorectal cancer screening.

Partners may have the option to cobrand the flyer with their organization’s logo. Contact your local American Cancer Society to learn more.

Colorectal Cancer Screening Best Practices: A Handbook for Hospitals and Health Systems

The purpose of the Colorectal Cancer Screening Best Practices: A Handbook for Hospitals and Health Systems is to provide advice on the design and delivery of a variety of effective CRC screening interventions to help all hospitals and health systems strengthen their colorectal cancer screening efforts.  With their expertise in both improving health and in serving as leaders in their communities, hospitals and health systems are uniquely positioned to play a pivotal role in increasing colorectal cancer screening for those they serve.  The handbook is divided into four sections:  Critical Steps, Case Studies, Implementation, and Tools & Resources. It is intended to provide you with needed information drawn from real life examples about how to ultimately improve CRC screening rates within the hospital and health system setting.

A corresponding webinar was held in July 2018 announcing the release of the handbook and included presentations from two health systems featured in the guide. View the Colorectal Cancer Screening Best Practices for Hospitals and Health Systems webinar.

Many thanks to the hospitals and health systems featured in the guide for sharing their time and their tremendous expertise, as well as to handbook’s expert advisory group, which was chaired by Drs. Michael Potter and Dorothy Lane, Co-Chairs of the NCCRT Professional Education and Practice Implementation Task Group.

This handbook is dedicated to the memory of Marie LaFargue.

Risk Assessment and Screening Toolkit to Detect Familial, Hereditary, and Early Onset Colorectal Cancer – June 19, 2018

This webinar introduced a new NCCRT resource for primary care providers, Risk Assessment and Screening Toolkit to Detect Familial, Hereditary and Early Onset Colorectal Cancer.  The new toolkit aims to improve the ability of primary care clinicians to systematically collect, document, and act on a family history of CRC and adenomas polyps, while also educating clinicians on the need for more timely diagnostic testing for young adults who present with alarm signs or symptoms of CRC and ensuring that those patients receive a proper diagnostic work up.  Speakers include:

  • Emily Edelman, MS, CGC, Associate Director, Clinical & Continuing Education, The Jackson Laboratory;
  • Dennis Ahnen, MD, Professor Emeritus, University of Colorado School of Medicine, NCCRT Steering Committee, NCCRT Co-Chair Family History and Early Age Onset CRC Task Group;
  • Paul Schroy, MD, MPH,  Professor of Medicine, Boston University School of Medicine, NCCRT Co-Chair Family History and Early Age Onset CRC Task Group;
  • Thomas Weber, MD, Director of Surgical Oncology, Northwest Region at Northwell Health, NCCRT Chair Emeritus, NCCRT Co-Chair Family History and Early Age Onset CRC Task Group. 

 

Risk Assessment And Screening Toolkit To Detect Familial, Hereditary And Early Onset Colorectal Cancer

Limited or inaccurate family history collection and risk assessment is a major barrier to successful cancer screening. Individuals who have a first-degree relative with colorectal cancer (CRC) are at least two times more likely to develop CRC, with the risk increasing with earlier ages of diagnosis and the number of relatives diagnosed with CRC. Therefore, screening and prevention efforts must focus on those with familial or hereditary risk, which requires collecting the necessary family history information for risk assessment. Primary care clinicians play a pivotal role in identifying people at increased CRC risk and facilitating recommended screening.

This new NCCRT toolkit aims to improve the ability of primary care clinicians to systematically collect, document, and act on a family history of CRC and adenomas polyps, while also educating clinicians on the need for more timely diagnostic testing for young adults who present with alarm signs or symptoms of CRC and ensuring that those patients receive a proper diagnostic work up. This toolkit serves as a comprehensive, step-by-step guide to improve operations within practices and suggests many useful resources and tools to aid these changes. 

Companion Quick Start Guide

Accompanying the full toolkit is a short, quick start guide with recommendations on how to ease into the transition process, while still making the critical improvements necessary for successful system-wide implementation. 

Thank you to the outstanding work and guidance provided from the NCCRT Family History and Early Age Onset Colorectal Cancer Task Group and the smaller project advisory group. Also, thank you to the excellent work from our project developers at The Jackson Laboratory. 

 

Sample Risk Assessment Screening Algorithm

These screening algorithms include recommended screening options for the average-risk and high-risk patient and provides as a sample starter policy for your practice. A policy that incorporates the considerations of risk level, insurance coverage, local medical resources, and patient preference will lead to the best screening choice for each patient. These sample algorithms also provide a review of screening options, helpful definitions to improve understanding, and coding assistance for Medicare patients. Two samples are provided for practices considering either the USPSTF screening recommendations or the 2018 American Cancer Society Colorectal Cancer Screening Guideline.